| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $104.6M | +0.0% | +10.3% |
| R&D Expense | $10.3M | +14.4% | +24.1% |
| SG&A Expense | $24.6M | +43.4% | +11.9% |
| Operating Income | $3.0M | -68.5% | +15.8% |
| Pre-tax Income | -$267K | -104.3% | +83.9% |
| Income Tax | -$1.8M | -121.8% | -517.9% |
| Net Income | $1.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $172.7M | +6.4% | -25.9% |
| Accounts Receivable | $76.9M | -7.5% | -19.8% |
| Current Assets | $283.3M | +0.7% | -19.2% |
| Total Assets | $1.54B | -0.5% | -0.5% |
| Current Liabilities | $135.5M | +3.9% | +10.4% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $67.5M | — | — |
| Capital Expenditures | $757K | — | — |
| Investing Cash Flow | -$19.5M | — | — |
| Financing Cash Flow | -$59.2M | — | — |
| Free Cash Flow | $66.8M | — | — |
| +177.5% |
| +211.2% |
| EPS (Basic) | $0.01 | +200.0% | +200.0% |
| EPS (Diluted) | $0.01 | +200.0% | +200.0% |
| $293.5M |
| -0.2% |
| -0.8% |
| Total Liabilities | $471.0M | -0.4% | -3.8% |
| Stockholders' Equity | $1.06B | -0.5% | +1.1% |